Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial - Wikidata - awgldk - TriplyDB

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

http://www.wikidata.org/entity/Q24807379

about

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.Making circadian cancer therapy practical.

P2860

Q31028277-2D6BA03F-DA5E-4B25-9C1D-71C95F389F22 Q37665041-81132906-6B2C-41BA-AFB1-33D5AE9FECF1

P2860

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

http://www.wikidata.org/entity/Q24807379

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@ast

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@en

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@nl

type

label

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@ast

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@en

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@nl

prefLabel

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@ast

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@en

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@nl

P1433

Q24807379-EA9CE56B-D45A-483F-A0F8-E874423BADC1

P1476

Q24807379-3E161D4E-8BB2-4015-9D7A-E2E59BDF71C9

P2093

Q24807379-049C6996-539F-4883-9648-2FE4E7671CEB

Q24807379-46C50D6C-9362-440B-A3A9-418BA88873AC

Q24807379-59EB5CC2-3E6D-435A-A4CA-254ABB70B55E

Q24807379-723D19F0-4862-41FD-B544-80EB9FF2EF0A

Q24807379-B1EF7FDD-437E-4D0E-8CB2-2C8B3C3C8FA6

Q24807379-D40E2D25-2E3E-48B6-B93C-7EA23ACC4335

Q24807379-F3DDF7C0-538E-429E-8633-7A0007227790

Q24807379-F97481D6-FE6C-41DB-8BEF-02CB330E01FF

P2860

Q24807379-11362DF8-0DA0-4624-A11E-8FBED5A8B379

Q24807379-1633E94D-5803-4BB5-BFF3-09BA7C15B86A

Q24807379-19AE8780-8620-4561-8B2A-C801D003042E

Q24807379-25AA566D-CF9A-419C-BA42-4444DC8F7642

Q24807379-28C2E57F-ACB1-4762-A61C-2076561ACF7B

Q24807379-3F939F2E-81A5-4623-9EAA-4BF531C50FE8

Q24807379-4334AC20-875F-4705-9E8E-8A20F0D90376

Q24807379-47EF1FA8-074F-4544-832F-6C4F63C7B693

Q24807379-5C0567F7-C175-41DE-92CD-76F858BA77AB

Q24807379-5EF6F0BA-9109-414A-B8F6-37E97033DDC3

P2888

Q24807379-94F8B285-7FBA-48E5-BED4-F449E0689564

P304

Q24807379-C174EF69-6B97-49E8-A5C2-C1A0BD637674

P31

Q24807379-0EAC9F1A-34E4-4D01-8C9B-906FDE44CF75

P356

Q24807379-B1BBF1C7-26BA-4C08-ACE9-76D9A5C69499

P433

Q24807379-997416D0-E16A-43DF-A776-74832C1A434C

P478

Q24807379-8954B9D4-FE46-4EAD-A1B9-03CE623A04BF

P50

Q24807379-28FA90B6-B6A4-407D-98BB-9140AE12CBE7

Q24807379-3861B7EC-FB15-4418-A157-C698FFA45E79

Q24807379-41CFE348-E838-4A67-A003-573B27BCA978

P577

Q24807379-AE337AA7-B3F3-4D68-906C-11733152143F

P5875

Q24807379-B818F2DE-74D1-48B6-B6E6-1FF537E686CC

P6179

Q24807379-7561C805-2459-4A6B-BCBE-6F940364BEBE

P698

Q24807379-CA0D8D5F-EB12-4551-965A-C59629C4852D

P921

Q24807379-80650ABB-323E-462A-86A6-33DDC4489F6A

Q24807379-C74516DC-DA95-441E-B335-B66D666834AB

P932

Q24807379-CAA7975F-8606-4746-B605-123ABDF0FD3C

P356

P1433

Journal of Translational Medicine

P1476

Fibrinogen: a novel predictor ...... an melanoma inter-group) trial

@en

P2093

Addolorata Casamassima

http://www.w3.org/2001/XMLSchema#string

Antonella Romanini

http://www.w3.org/2001/XMLSchema#string

Antonio Freschi

http://www.w3.org/2001/XMLSchema#string

Michele Guida

http://www.w3.org/2001/XMLSchema#string

Ruggero Ridolfi

http://www.w3.org/2001/XMLSchema#string

Salvatore Brugnara

http://www.w3.org/2001/XMLSchema#string

Vanna Chiarion Sileni

http://www.w3.org/2001/XMLSchema#string

Vito Lorusso

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2001

Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival.

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-1-13

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Labianca

Alessandra Ravaioli

P577

2003-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5541691

http://www.w3.org/2001/XMLSchema#string

P6179

1029803255

http://www.w3.org/2001/XMLSchema#string

P698

14690541

http://www.w3.org/2001/XMLSchema#string

P921

P932

320500

http://www.w3.org/2001/XMLSchema#string